Literature DB >> 27425386

Expression of Markers of Hepatocellular Differentiation in Pancreatic Acinar Cell Neoplasms:  A Potential Diagnostic Pitfall.

Gokce Askan1, Vikram Deshpande2, David S Klimstra1, Volkan Adsay3, Carlie Sigel1, Jinru Shia1, Olca Basturk4.   

Abstract

OBJECTIVES: Pancreatic acinar cell carcinoma (ACC) is a rare tumor that frequently metastasizes to the liver and may present a diagnostic challenge due to its morphologic similarity to hepatocellular carcinoma. We investigated α-fetoprotein (AFP), hepatocyte paraffin antigen 1 (HepPar 1), glypican 3, arginase 1, and albumin messenger RNA (mRNA) in situ hybridization (ISH) in pancreatic neoplasms with ACC differentiation to assess their diagnostic value.
METHODS: AFP, HepPar 1, glypican 3, and arginase 1 immunohistochemical staining was performed on 28 ACCs using a tissue microarray. Albumin mRNA ISH was performed on full-faced sections.
RESULTS: Fifteen tumors were positive for at least one marker. Glypican 3 was positive in seven of 28, AFP in five 28, and albumin mRNA ISH in five of 20. None expressed arginase 1.
CONCLUSIONS: Hepatocellular differentiation markers, including albumin mRNA ISH, may be positive in ACC, but arginase 1 appears to be uniformly negative. Thus, its use may improve the accuracy in distinguishing these neoplasms from hepatocellular carcinoma. If ACC diagnosis is considered, acinar differentiation can be reliably demonstrated by trypsin/chymotrypsin. © American Society for Clinical Pathology, 2016. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Acinar cell carcinoma; Albumin ISH; Arginase 1; Glypican 3; Hepatocellular carcinoma; Pancreas

Mesh:

Substances:

Year:  2016        PMID: 27425386      PMCID: PMC5731433          DOI: 10.1093/ajcp/aqw096

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  46 in total

1.  Dicer is required for proper liver zonation.

Authors:  Shigeki Sekine; Reiko Ogawa; Michael T Mcmanus; Yae Kanai; Matthias Hebrok
Journal:  J Pathol       Date:  2009-11       Impact factor: 7.996

2.  Expression of Albumin mRNA in Primary Hepatic Neoplasms and Acinar Cell Carcinoma.

Authors:  David T Ting; Vikram Deshpande
Journal:  Am J Surg Pathol       Date:  2015-08       Impact factor: 6.394

3.  Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling.

Authors:  Yutaka Midorikawa; Shumpei Ishikawa; Hiroko Iwanari; Takeshi Imamura; Hirohiko Sakamoto; Kohei Miyazono; Tatsuhiko Kodama; Masatoshi Makuuchi; Hiroyuki Aburatani
Journal:  Int J Cancer       Date:  2003-02-10       Impact factor: 7.396

4.  Hepatocellular oncofetal protein, glypican 3 is a sensitive marker for alpha-fetoprotein-producing gastric carcinoma.

Authors:  M Hishinuma; K-I Ohashi; N Yamauchi; T Kashima; H Uozaki; S Ota; T Kodama; H Aburatani; M Fukayama
Journal:  Histopathology       Date:  2006-11       Impact factor: 5.087

5.  Immunoreactivity of Hep Par 1 in hepatic and extrahepatic tumors and its correlation with albumin in situ hybridization in hepatocellular carcinoma.

Authors:  Sanjay Kakar; Trudie Muir; Linda M Murphy; Ricardo V Lloyd; Lawrence J Burgart
Journal:  Am J Clin Pathol       Date:  2003-03       Impact factor: 2.493

6.  Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein.

Authors:  Peiguo G Chu; Shin Ishizawa; Emerald Wu; Lawrence M Weiss
Journal:  Am J Surg Pathol       Date:  2002-08       Impact factor: 6.394

7.  In situ hybridization of albumin mRNA in normal liver and liver tumors: identification of hepatocellular origin.

Authors:  K Yamaguchi; M A Nalesnik; B I Carr
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1993

8.  Immunocytochemical diagnosis of hepatocellular carcinoma and identification of carcinomas of unknown primary metastatic to the liver on fine-needle aspiration cytologies.

Authors:  Alexandre Sherlley Casimiro Onofre; Natalia Pomjanski; Birgit Buckstegge; Alfred Böcking
Journal:  Cancer       Date:  2007-08-25       Impact factor: 6.860

Review 9.  Best practices in diagnostic immunohistochemistry: hepatocellular carcinoma versus metastatic neoplasms.

Authors:  Sanjay Kakar; Allen M Gown; Zachary D Goodman; Linda D Ferrell
Journal:  Arch Pathol Lab Med       Date:  2007-11       Impact factor: 5.534

10.  Glypican-3 expression in primary and recurrent ovarian carcinomas.

Authors:  Sylvia Stadlmann; Uwe Gueth; Daniel Baumhoer; Holger Moch; Luigi Terracciano; Gad Singer
Journal:  Int J Gynecol Pathol       Date:  2007-07       Impact factor: 2.762

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.